Patterns of relapse after autologous purged bone marrow transplantation for neuroblastoma: A childrens cancer group pilot study

Journal of Clinical Oncology

Volumn 11, Issue 11, 1993, Pages 2226-2233

  Matthay, Katherine K ^a   Atkinson, James B ^a   Strom, Daniel O ^a   Selch, Michael ^a   Patrick Reynolds, C ^a   Seeger, Robert C ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; DOXORUBICIN; ETOPOSIDE; MELPHALAN; TENIPOSIDE;

ADOLESCENT; ADULT; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; BONE METASTASIS; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CHILD; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROBLASTOMA; PRIORITY JOURNAL; WHOLE BODY RADIATION;

ACTUARIAL ANALYSIS; ADOLESCENT; BONE MARROW DISEASES; BONE MARROW PURGING; BONE MARROW TRANSPLANTATION; CHILD; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; HUMAN; INFANT; LIFE TABLES; NEOPLASM RECURRENCE, LOCAL; NEUROBLASTOMA; PILOT PROJECTS; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; SURVIVAL ANALYSIS; TRANSPLANTATION, AUTOLOGOUS; TREATMENT FAILURE;

EID: 0027486042     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1993.11.11.2226     Document Type: Article

References (32)

1. Seeger RC, Villablanca JG, Matthay KK, et al: Intensive chemoradiotherapy and autologous bone marrow transplantation for poor prognosis neuroblastoma. Prog Clin Biol Res 366:527-533, 1991
2. Graham-Pole J, Casper J, Elfenbein G, et al: High-dose chemoradiotherapy supported by marrow infusions for advanced neuroblastoma: A Pediatric Oncology Group study. Clin Oncol 9:152-158, 1991 (erratum in J Clin Oncol 9:1094, 1991)
3. Philip T, Zucker JM, Bernard JL, et al: Improved survival at 2 and 5 years in the LMCE1 unselected group of 72 children with stage IV neuroblastoma older than 1 year of age at diagnosis: Is cure possible in a small subgroup? J Clin Oncol 9:1037-1044, 1991
4. Kushner BH, O'Reilly RJ, Mandell LR, et al: Myeloablative combination chemotherapy without total body irradiation for neuroblastoma. J Clin Oncol 9:274-279, 1991
5. Dini G, Lanino E, Garaventa A, et al: Myeloablative therapy and unpurged autologous bone marrow transplantation for poor-prognosis neuroblastoma: Report of 34 cases. J Clin Oncol 9:962-969, 1991
6. Seeger RCI, Reynolds CP: Treatment of high risk solid tumors of childhood with intensive therapy and autologous bone marrow transplantation. Pediatr Clin North Am 38:393-424, 1991
7. Haase GM, O'Leary MC, Ramsay NK, et al: Aggressive surgery combined with intensive chemotherapy improves survival in poor-risk neuroblastoma. J Pediatr Surg 26:1119-1124, 1991
8. Glorieux P, Bouffet E, Philip I, et al: Metastatic interstitial pneumonitis after autologous bone marrow transplantation: A consequence of reinjection of malignant cells? Cancer 58:2136-2139, 1986
9. Philip T, Zucker JM, et al: Bone marrow transplantation in an unselected group of 65 patients with stage IV neuroblastoma, in Dicke KA. Spitzer G, Jagannath S (eds): Autologous Marrow Transplantation: Proceedings of the Third International Symposium. Houston, TX, M.D. Anderson Hospital and Tumor Institute. 1987, pp 407-417
10. Moss TJ, Reynolds CP, Sather HN, et al: Prognostic value of immunocytologic detection of bone marrow metastases in neuroblastoma. N Engl J Med 324:219-226, 1991
11. Brodeur GM, Seeger RC, Barrett A, et al: International criteria for diagnosis, staging, and response to treatment in patients with neuroblastoma. J Clin Oncol 6:1874-1881, 1988
12. Shimada H, Chatten J, Newton WA, et al: Histopathologic prognostic factors in neuroblastic tumors: Definition of subtypes of ganglioneuroblastoma and an age-linked classification of neuroblastomas J Natl Cancer Inst 73:405-416, 1984
13. Chatten J, Shimada H, Sather HN, et al: Prognostic value of histopathology in advanced neuroblastoma: A report from the Childrens Cancer Study Group. Hum Pathol 19:1187-1198, 1988
14. Mann HWL, Evans AE, Siegel SE, et al: Prognostic importance of serum ferritin in patients with stages III and IV neuroblastoma: The Childrens Cancer Study Group experience. Cancer Res 45:2843-2848, 1985
15. Seeger RC, Brodeur GM, Sather H, et al: Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas. N Engl J Med 313:1111-1116, 1985
16. Matthay KK, Moss TJ, Xu Z, et al: Length of induction therapy is critical for preparing patients with advanced neuroblastoma for bone marrow transplantation. Proc Am Soc Clin Oncol 7:257, 1988 (abstr)
17. O'Leary MC, Sather HN, Ramsay NK, et al: Intensive chemotherapy for poor prognosis neuroblastoma. Proc Am Assoc Cancer Res 31:201, 1990 (abstr)
18. Reynolds CP, Seeger RC, Vo DD, et al: Model system for removing neuroblastoma cells from bone marrow using monoclonal antibodies and magnetic immunobeads. Cancer Res 46:5882-5886, 1986
19. Kaplan E, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457-481, 1958
20. Seeger RC, Moss TJ, Feig SA, et al: Bone marrow transplantation for poor prognosis neuroblastoma. Prog Clin Biol Res 271:203-213, 1988
21. Haase GM, Wong KY, deLorimier AA, et al: Improvement in survival after excision of primary tumor in stage III neuroblastoma. J Pediatr Surg 24:194-200, 1989
22. Matsumura M, Atkinson JB, Hays DM, et al: An evaluation of the role of surgery in metastatic neuroblastoma. J Pediatr Surg 23:448-453, 1988
23. Ikeda H, August CS, Goldwein JW, et al: Sites of relapse in patients with neuroblastoma following bone marrow transplantation in relation to preparatory debulking treatments. J Pediatr Surg 27:1438-1441, 1992
24. Cheung NKV, Yeh SDJ, Gulai S, et al: 1311-3F8: Clinical validation of imaging studies and therapeutic applications. Prog Clin Biol Res 366:409-415, 1991
25. 131I-metaiodobenzyl-guanidine (MIBG) therapy for patients with refractory neuroblastoma. J Nucl Biol Med 35:244-247, 1992
26. Reynolds CP, Kane DJ, Einhorn PA, et al: Response of neuroblastoma to retinoic acid in vitro and in vivo. Prog Clin Biol Res 366:203-211, 1991
27. Finklestein JZ, Krailo MD, Lenarsky C, et al: 13-cis-retinoic acid (NSC 122758) in the treatment of children with metastatic neuroblastoma unresponsive to conventional chemotherapy: Report from the Childrens Cancer Study Group. Med Pediatr Oncol 20:307-311, 1992
28. Negrier S, Michon J, Floret D, et al: Intcrleukin-2 and lymphokine-activated killer cells in 15 children with advanced metastatic neuroblastoma. J Clin Oncol 9:1363-1370, 1991
29. Favrot MC, Floret U, Negrier S, et al: Systemic interleukin-2 therapy in children with progressive neuroblastoma after high dose chemotherapy and bone marrow transplantation. Bone Marrow Transplant 4:499-503, 1989
30. D2 specific monoclonal antibody 3F8: A phase I study in patients with neuroblastoma and malignant melanoma. J Clin Oncol 5:1430-1440, 1987
31. Kushner BH, Cheung N-K: GM-CSF enhances 3F8 monoclonal antibody-dependent cellular cytotoxicity against human melanoma and neuroblastoma. Blood 73:1936-1941, 1989
32. Matthay KK, Seeger RC, Reynolds CP, et al: Comparison of autologous and allogeneic bone marrow transplantation for neuroblastoma. Proc Am Soc Clin Oncol 12:414, 1993 (abstr)